News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
626,697 Results
Type
Article (23250)
Company Profile (192)
Press Release (603250)
Multimedia
Podcasts (34)
Webinars (12)
Section
Business (198973)
Career Advice (762)
Deals (30033)
Drug Delivery (96)
Drug Development (67868)
Employer Resources (52)
FDA (14450)
Job Trends (11565)
News (292555)
Policy (24964)
Tag
2025 Best Places to Work (8)
2026 Best Places to Work (15)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Standard (1)
40 Under 40 (3)
Academia (1817)
Accelerated approval (52)
ADA (39)
Adcomms (11)
Allergies (171)
Alliances (43153)
ALS (186)
Alzheimer's disease (1537)
Antibody-drug conjugate (ADC) (531)
Approvals (15352)
Artificial intelligence (731)
ASCO (243)
Autoimmune disease (439)
Automation (68)
Bankruptcy (279)
Belgium (24)
Best Places to Work (9526)
BIO (58)
Biologics (96)
BIOSECURE Act (5)
Biosimilars (206)
BioSpace Insights (71)
Biotechnology (121)
Bispecific (46)
Bladder cancer (201)
Brain cancer (67)
Breast cancer (746)
Cancer (5926)
Cardiovascular disease (624)
Career advice (643)
Career pathing (20)
CAR-T (313)
CDC (17)
CDMO (96)
Celiac Disease (3)
Cell therapy (856)
Cervical cancer (54)
Clinical research (61733)
Collaboration (2117)
Commercialization (57)
Company closure (1)
Compensation (1734)
Complete response letters (50)
COVID-19 (1716)
CRISPR (120)
CRO (3)
C-suite (1180)
Cystic fibrosis (118)
Data (9281)
Decentralized trials (3)
Denatured (13)
Depression (140)
Dermatology (158)
Diabetes (633)
Diagnostics (6042)
Digital health (71)
Diversity (5)
Diversity, equity & inclusion (18)
Drug discovery (339)
Drug pricing (96)
Drug shortages (12)
Duchenne muscular dystrophy (239)
Earnings (83114)
Editorial (20)
Employer branding (2)
Employer resources (53)
ESMO (322)
Events (106721)
Executive appointments (971)
Eye disease (18)
FDA (18691)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (4)
Friedreich's ataxia (24)
Frontotemporal dementia (31)
Funding (1616)
Gene editing (234)
Generative AI (55)
Gene therapy (619)
GLP-1 (745)
Government (2523)
Grass and pollen (3)
Guidances (379)
Healthcare (14796)
Hematology (176)
HIV (82)
Huntington's disease (45)
Idiopathic pulmonary fibrosis (10)
IgA nephropathy (119)
Immunology and inflammation (233)
Immuno-oncology (115)
Indications (260)
Infectious disease (2024)
Inflammatory bowel disease (203)
Inflation Reduction Act (8)
Influenza (128)
Intellectual property (323)
Interviews (97)
IPO (14085)
IRA (19)
Job creations (2465)
Job search strategy (567)
JPM (22)
Kidney cancer (23)
Kidney disease (135)
Labor market (12)
Layoffs (166)
Leadership (13)
Legal (6140)
Licensing (97)
Liver cancer (78)
Longevity (46)
Lung cancer (821)
Lung diease (15)
Lymphoma (461)
Machine learning (56)
Management (20)
Manufacturing (1055)
Marketing (35)
MASH (190)
Medical affairs (3)
Medical device (13027)
Medtech (13324)
Mergers & acquisitions (17325)
Metabolic disorders (1386)
Middle East (1)
mRNA (177)
Multiple sclerosis (222)
Multispecific (6)
NASH (10)
Netherlands (24)
Neurodegenerative disease (409)
Neuropsychiatric disorders (77)
Neuroscience (3092)
Neurotech (3)
NextGen: Class of 2026 (4875)
Non-profit (2315)
Now hiring (26)
Obesity (535)
Opinion (164)
Ovarian cancer (243)
Pain (283)
Pancreatic cancer (313)
Parkinson's disease (349)
Partnered (28)
Patents (654)
Patient advocacy (4)
Patient recruitment (771)
Patient selection (92)
Peanut (68)
People (50157)
Peptides (33)
Pharmaceutical (36)
Pharmacy benefit managers (24)
Phase 1 (19540)
Phase 2 (27087)
Phase 3 (19687)
Pipeline (12313)
Policy (138)
Postmarket research (2162)
Preclinical (8416)
Press Release (52)
Prostate cancer (283)
Psychedelics (28)
Radiopharmaceuticals (284)
Rare diseases (1003)
Real estate (4194)
Recruiting (22)
Regenerative medicine (23)
Regulatory (21727)
Reports (34)
Research institute (1748)
Resumes & cover letters (129)
Rett syndrome (55)
RNA editing (19)
RSV (69)
Saudi Arabia (1)
Schizophrenia (167)
Series A (286)
Series B (199)
Service/supplier (6)
Sickle cell disease (95)
Special edition (9)
Spinal muscular atrophy (136)
Sponsored (34)
Startups (2852)
State (1)
Stem cells (8)
Stomach cancer (11)
Substance use disorders (17)
Supply chain (101)
Switzerland (15)
Tariffs (19)
Tax incentives (1)
The Weekly (19)
Vaccines (729)
Venture capital (68)
Weight loss (279)
Wet AMD (5)
Women's health (136)
Worklife (3)
Date
Today (145)
Last 7 days (731)
Last 30 days (3245)
Last 365 days (25844)
2026 (23460)
2025 (25043)
2024 (29323)
2023 (33567)
2022 (43321)
2021 (46926)
2020 (44365)
2019 (35104)
2018 (26306)
2017 (25816)
2016 (24983)
2015 (31500)
2014 (26944)
2013 (22758)
2012 (24846)
2011 (25272)
2010 (24472)
Location
Africa (467)
Alabama (94)
Alaska (3)
Arizona (408)
Arkansas (15)
Asia (29653)
Australia (4063)
California (15218)
Canada (3985)
China (1280)
Colorado (681)
Connecticut (610)
Delaware (388)
Europe (57577)
Florida (2389)
Georgia (504)
Hawaii (3)
Idaho (58)
Illinois (1097)
India (116)
Indiana (639)
Iowa (25)
Japan (630)
Kansas (131)
Kentucky (49)
Louisiana (55)
Maine (39)
Maryland (1622)
Massachusetts (10492)
Michigan (364)
Minnesota (812)
Mississippi (7)
Missouri (150)
Montana (31)
Nebraska (22)
Nevada (192)
New Hampshire (74)
New Jersey (3836)
New Mexico (24)
New York (3869)
North Carolina (1713)
North Dakota (10)
Northern California (7888)
Ohio (417)
Oklahoma (25)
Oregon (34)
Pennsylvania (2844)
Puerto Rico (30)
Rhode Island (46)
South America (702)
South Carolina (94)
South Dakota (2)
Southern California (6164)
Tennessee (212)
Texas (2509)
United States (52087)
Utah (467)
Vermont (2)
Virginia (301)
Washington D.C. (51)
Washington State (1250)
West Virginia (2)
Wisconsin (132)
Wyoming (3)
626,697 Results for "cardiovascular systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Psychedelics
Deep dive: Cardiovascular calamities and catalysts
BioSpace
reviews upcoming cardiovascular milestones after a summer of missed targets.
November 12, 2026
·
3 min read
·
Heather McKenzie
Press Releases
enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium
November 2, 2026
·
4 min read
Press Releases
New Cardiovascular Device Approved in Japan: Elixir Medical Announces Regulatory Approval of DynamX® Coronary Bioadaptor System
September 14, 2026
·
5 min read
FDA
Lilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist Mounjaro
With the approval, Eli Lilly’s Mounjaro becomes the first dual GIP/GLP-1 receptor agonist indicated to lower the risk of heart attack, stroke or cardiovascular death in adults with type 2 diabetes.
August 28, 2026
·
2 min read
·
Heather McKenzie
Cardiovascular disease
Novo’s IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9%
Novo Nordisk’s IL-6 inhibitor ziltivekimab failed to reduce the risk of cardiovascular events in the late-stage trial, dashing hopes for an edge in the hyper-competitive cardiometabolic space.
July 31, 2026
·
2 min read
·
Michael Gibney
Press Releases
New Cardiovascular Research From NYU Langone Heart at AHA Scientific Sessions 2026
November 6, 2026
·
9 min read
Press Releases
Atman Health forms Strategic Advisory Board as It builds AI-Driven Autonomous Cardiovascular Care
November 10, 2026
·
3 min read
Press Releases
Remedy Robotics Raises $62 Million Series B to Bring Life-Saving Cardiovascular Intervention to Patients Everywhere
November 16, 2026
·
6 min read
Cardiovascular disease
Details from Novartis’ failed cardiovascular trial offer ‘little silver lining’ for rivals
Full data from the Phase 3 HORIZON trial of Novartis’ pelacarsen failed to show any apparent benefit, leading analysts to further reduce the odds of success for Lp(a)-lowering competitors such as Amgen’s olpasiran.
November 9, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Philips highlights Integrated Diagnostics’ role in the future of cardiovascular informatics following MediReport acquisition
October 20, 2026
·
4 min read
1 of 62,670
Next